Related references
Note: Only part of the references are listed.Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges
Somnath Singh et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
In vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions
Xiang-Rui Liu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Cremophor-free intravenous microemulsions for paclitaxel I: Formulation, cytotoxicity and hemolysis
Adwoa O. Nornoo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics
Adwoa O. Nornoo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
D. -W. Kim et al.
ANNALS OF ONCOLOGY (2007)
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL(R)-free formulation of paclitaxel
Thomas E. Stinchcombe
NANOMEDICINE (2007)
Phase I and pharmacokinetic study of Al-850, a novel microparticle hydrophobic drug delivery system for paclitaxel
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2007)
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles
Janos Szebeni et al.
JOURNAL OF LIPOSOME RESEARCH (2007)
Novel formulations of taxanes: a review. Old wine in a new bottle?
KL Hennenfent et al.
ANNALS OF ONCOLOGY (2006)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile
L He et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Comparative pharmacokineties of unbound paclitaxel during 1-and 3-hour infusions
H Gelderblom et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions
J Szebeni et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Microemulsion-based media as novel drug delivery systems
MJ Lawrence et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Share Paper
